Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cardiovascular disease
MedTech
Edwards highlights 8-year durability data for its Resilia valves
Edwards Lifesciences put forward new clinical data showing its bioprosthetics can maintain function over the long term.
Conor Hale
Apr 18, 2025 11:30am
Edwards nets mitral valve replacement approval in Europe
Apr 15, 2025 11:00am
Artificial heart maker Picard Medical plans to go public
Apr 1, 2025 12:30pm
AZ's oral PCSK9 inhibitor halves bad cholesterol in phase 2
Mar 31, 2025 12:00pm
Lilly links lepodisiran to durably lower lipoprotein in phase 2
Mar 31, 2025 4:24am
Kardigan weaves health tech firm Prolaio into cardio R&D fabric
Mar 27, 2025 9:00am
